Exubera Bong Bombs!

Pfizer announced that it will no longer market Exubera, an inhaled insulin device that it just began to promote heavily on TV."We made an important decision regarding Exubera, a product for...

Transparency: A New Voice for Pharma

The upcoming Pharmaceutical Public Relations & Communications Summit will feature many presentations from pharmaceutical communications and PR specialists who will attempt to offer advice on how to make pharmaceutical crises "go...

GSK’s “Plain Talk” Flawed

This discussion starts with the post I made a few days ago about GlaxoSmithKline (GSK) using sales reps to spread the word about the value of brand drugs (see "Sales Reps...

On Being Voted Off the Social Media Island

Here's a bit of irony. Today, I was virtually "voted off" the social media (Twitter) island of #hcsmeu by @FarmerFunster for being too promotional. The irony is that many of the...

Patient Advocacy Marketing: US vs Them

It's hard to do pharmaceutical marketing in the UK and the rest of Europe, which probably explains why my Pharma Marketing News subscriber list is only about 20% European.Here's just one...

An Analysis of Genentech’s 4HER Mobile Health App Privacy Policy

Genentech's 4HER iPhone App for women with HER2 breast cancer is interesting and perhaps unique in a Mobile Health App developed by a pharma company. The app allows users to send...

FDA Promises Final Mobile App Guidance by October 2013 & Sets Limits on What...

In testimony at the March 21, 2013 House Subcommittee on Oversight and Investigations regarding Health Information Technologies: Administration Perspectives on Innovation and Regulation, Christy Foreman, Director of FDA's Office of Device Evaluation,...

FDA: Zimulti Non-Acomplia!

As reported in the Wall Street Journal Health Blog, an FDA advisory panel unanimously rejected Zimulti:By a unanimous vote, a panel of experts convened by the FDA just rejected Sanofi-Aventis's weight-loss...

Palio Ignited a ISIS-style Disruptive – Some Might Say Destructive – Full Page Ad...

Click on image for enlarged view I still get the print version of Pharmaceutical Executive magazine. These days the mag is much thinner than in its glory years - only 60 pages,...

Finally, a Drug Company Embraces Social Media, AEs Included!

Adverse events! Adverse events! Adverse events!How many times have you heard that tiresome phrase from pharmaceutical companies as an excuse for NOT embracing social media marketing?Practically every social media endeavor...

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -